Relcer (Tablets, Suspension) Instructions for Use

ATC Code

A02AF02 (Simple combinations of salts and carminatives)

Clinical-Pharmacological Group

Antacid drug with an antiflatulent component

Pharmacotherapeutic Group

Antacid agent + carminative agent

Pharmacological Action

Antacid agent with an antiflatulent component. It neutralizes free hydrochloric acid in the stomach, which leads to a decrease in pepsin activity. It does not cause secondary gastric hypersecretion. It has an adsorbent and enveloping effect, reducing the influence of damaging factors on the gastric mucosa. It accelerates the healing of gastric and duodenal ulcers. It reduces gas formation in the intestine.

The simethicone included in the preparation reduces gas formation in the intestine. Deglycyrrhizinated licorice root extract enhances the protective effect on the gastric mucosa, promoting the regeneration of mucosal cells, improving the quality and quantity of mucus, and also has an antispasmodic effect.

The preparation accelerates the healing of gastric and duodenal ulcers.

Pharmacokinetics

The absorption of the components of this combination is low.

Indications

Peptic ulcer of the stomach and duodenum in the acute phase; hiatal hernia, reflux esophagitis; discomfort and pain in the epigastrium, dyspeptic symptoms (heartburn, sour belching) due to dietary indiscretions, excessive consumption of coffee, nicotine, and alcohol; prevention and treatment of dyspeptic symptoms resulting from the use of NSAIDs and corticosteroids; acute gastritis, chronic gastritis with increased and normal secretory function in the acute phase, duodenitis.

ICD codes

Dosage Regimen

Administer orally, three to four times daily.

Take after meals and in the evening before bedtime.

Use as needed for discomfort, epigastric pain, or heartburn.

Adhere strictly to the prescribed dose based on the patient’s age.

Continue therapy for a duration of 14 days.

Consult a physician for any decision regarding longer-term use.

Chew tablets thoroughly before swallowing.

Shake the suspension well immediately before each use.

Do not exceed the maximum daily dosage.

Maintain a 1-2 hour interval between this medication and other drugs.

Seek medical supervision for use extending beyond 14 days.

Adverse Reactions

From the digestive system constipation, nausea, vomiting, stomach cramps, change in taste sensations.

From the water-electrolyte balance hypermagnesemia, hypophosphatemia, hypocalcemia, hypercalciuria, hyperaluminemia.

From the urinary system nephrocalcinosis, impaired renal function.

From the musculoskeletal system osteomalacia, osteoporosis.

Other encephalopathy, allergic reactions. In patients with concomitant renal insufficiency – thirst, decreased blood pressure, hyporeflexia.

Contraindications

Severe renal impairment; Alzheimer’s disease; pregnancy; lactation (breastfeeding) period; children under 10 years of age; hypersensitivity to the components of the combination.

Use in Pregnancy and Lactation

Contraindicated for use during pregnancy and breastfeeding.

Use in Renal Impairment

Contraindicated in severe renal impairment.

Pediatric Use

Contraindication: children under 10 years of age.

Geriatric Use

Use with caution in elderly patients to avoid the development of complications.

Special Precautions

The interval between taking this combination and other medicines should be 1-2 hours.

With long-term use (more than 14 days), regular medical supervision is necessary.

Drug Interactions

With simultaneous use, this combination can adsorb some medicines, thus reducing their absorption. This combination reduces and slows the absorption of digoxin, indomethacin, salicylates, chlorpromazine, phenytoin, histamine H₂-receptor blockers, beta-blockers, diflunisal, isoniazid, tetracycline antibiotics, quinolones (including ciprofloxacin, norfloxacin, ofloxacin, enoxacin, grepafloxacin), azithromycin, cefpodoxime, pivampicillin, rifampicin, indirect anticoagulants, barbiturates, fexofenadine, dipyridamole, zalcitabine, bile acids (chenodeoxycholic and ursodeoxycholic), penicillamine, iron and lithium preparations, quinidine, lansoprazole, mexiletine, ketoconazole.

When taken simultaneously with drugs in enteric-coated dosage forms, a change in the pH of gastric juice (more alkaline reaction) can lead to accelerated destruction of the coating and cause irritation of the gastric and duodenal mucosa.

When used concomitantly, M-cholinoblockers, by slowing gastric emptying, enhance and prolong the effect of this combination.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.